Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1675574
                    [Title] => Disease prevention via genetic testing
                    [Summary] => There are those who are afraid to go to a doctor because they do not want to know what’s wrong with them.
                    [DatePublished] => 2017-03-01 00:00:00
                    [ColumnID] => 134315
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 200814
                    [Title] => Prophylactic oophorectomy cuts Ca risk 75% in BRCA mutation carriers
                    [Summary] => Women at increased risk for breast and ovarian cancer due to BRCA1 and BRCA2 gene mutations can decrease that risk by 75 percent through prophylactic oophorectomy, according to results of the first prospective follow-up study to evaluate the effects of the procedure. Previous case-control studies have suggested that risk-reducing salpingo-oophorectomy is associated with a decreased incidence of both breast and ovarian cancer in BRCA mutation carriers, but this is the first prospective series to do so.
                    [DatePublished] => 2003-03-30 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

BRCA

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1675574
                    [Title] => Disease prevention via genetic testing
                    [Summary] => There are those who are afraid to go to a doctor because they do not want to know what’s wrong with them.
                    [DatePublished] => 2017-03-01 00:00:00
                    [ColumnID] => 134315
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 200814
                    [Title] => Prophylactic oophorectomy cuts Ca risk 75% in BRCA mutation carriers
                    [Summary] => Women at increased risk for breast and ovarian cancer due to BRCA1 and BRCA2 gene mutations can decrease that risk by 75 percent through prophylactic oophorectomy, according to results of the first prospective follow-up study to evaluate the effects of the procedure. Previous case-control studies have suggested that risk-reducing salpingo-oophorectomy is associated with a decreased incidence of both breast and ovarian cancer in BRCA mutation carriers, but this is the first prospective series to do so.
                    [DatePublished] => 2003-03-30 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Disease prevention via genetic testing

March 1, 2017 - 12:00am

There are those who are afraid to go to a doctor because they do not want to know what’s wrong with them.

Business

Prophylactic oophorectomy cuts Ca risk 75% in BRCA mutation carriers

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | March 30, 2003 - 12:00am

Women at increased risk for breast and ovarian cancer due to BRCA1 and BRCA2 gene mutations can decrease that risk by 75 percent through prophylactic oophorectomy, according to results of the first prospective follow-up...

Opinion